NOHRA GUY P 4

What Happened

• Guy P. Nohra, a director of Bioventus, had 32,282 restricted stock units (RSUs) vest on June 2, 2026 and the filing shows those RSUs were converted/exercised into 32,282 shares (reported as acquired at $0.00). The filing also reports a simultaneous disposition of 32,282 shares at $0.00 (derivative). On June 3, 2026 the filing reports an acquisition (award/grant) of 25,146 RSUs at $0.00.
• No cash price or market value is listed on the Form 4 for these entries (all reported at $0.00); the filing treats these as derivative transactions tied to RSUs rather than open-market purchases or sales.

Key Details

• Transaction dates: June 2, 2026 (RSU vest/convert and disposition) and June 3, 2026 (award/grant).
• Reported amounts/prices: 32,282 shares converted/acquired @ $0.00 and 32,282 shares disposed @ $0.00 on 6/2; 25,146 RSUs reported as granted/acquired @ $0.00 on 6/3.
• Footnotes: F1 — each RSU equals a contingent right to one share of Class A common stock; F2 — the RSUs vested on June 2, 2026; F3 — certain RSUs vest on the earlier of the next annual meeting or one year from grant, subject to continued board service.
• Shares owned after the transactions: not specified in the summary data you provided (not reported here).
• Filing timeliness: Report lists period ending 2026-06-02 and was filed 2026-06-04, consistent with a timely Form 4 filing (within required reporting window).

Context

• These entries reflect RSU vesting/settlement and a contemporaneous disposition of an equal number of shares. That pattern is commonly used to satisfy tax withholding when RSUs vest (i.e., shares are surrendered or netted to cover taxes), but the Form 4 reports only the mechanics (conversion/award and disposition) without stating the specific purpose.
• This is not an open-market buy or sale that signals a direct bullish or bearish trade by the insider; it's compensation-related equity activity (vesting and a subsequent RSU grant).